Screening for post-stroke depression involves evaluating the optimal patient populations, timing, and assessment tools to effectively identify and manage the condition.
Absolute Event Rate: 0% vs 0%
Depression is a common sequela of stroke, with about 30% of stroke survivors developing depression.1 The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM5) recognises poststroke depression within the category “Depressive disorder due to another medical condition”.2 Poststroke depression significantly hinders patients’ ability to participate in rehabilitation and is associated with poor health outcomes. Despite its high prevalence and negative impact, poststroke depression is vastly underdiagnosed.3 One estimate suggested that only 5% of stroke survivors are diagnosed with and treated for depression in routine clinical practice.4 Diagnosis of depression can be challenging in stroke survivors, especially in those who have residual communication and cognitive impairments.
Sewell et al. (Mon,) reported a other. Screening for post-stroke depression involves evaluating the optimal patient populations, timing, and assessment tools to effectively identify and manage the condition.